These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 25634554)

  • 1. Targets for therapy in sarcomeric cardiomyopathies.
    Tardiff JC; Carrier L; Bers DM; Poggesi C; Ferrantini C; Coppini R; Maier LS; Ashrafian H; Huke S; van der Velden J
    Cardiovasc Res; 2015 Apr; 105(4):457-70. PubMed ID: 25634554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic advances in sarcomeric cardiomyopathies: state of the art.
    Ho CY; Charron P; Richard P; Girolami F; Van Spaendonck-Zwarts KY; Pinto Y
    Cardiovasc Res; 2015 Apr; 105(4):397-408. PubMed ID: 25634555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.
    Olivotto I; d'Amati G; Basso C; Van Rossum A; Patten M; Emdin M; Pinto Y; Tomberli B; Camici PG; Michels M
    Cardiovasc Res; 2015 Apr; 105(4):409-23. PubMed ID: 25631583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research priorities in sarcomeric cardiomyopathies.
    van der Velden J; Ho CY; Tardiff JC; Olivotto I; Knollmann BC; Carrier L
    Cardiovasc Res; 2015 Apr; 105(4):449-56. PubMed ID: 25631582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcomeric cardiomyopathies: from bedside to bench and back.
    Hasenfuss G
    Cardiovasc Res; 2015 Apr; 105(4):395-6. PubMed ID: 25681397
    [No Abstract]   [Full Text] [Related]  

  • 6. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
    Eschenhagen T; Mummery C; Knollmann BC
    Cardiovasc Res; 2015 Apr; 105(4):424-38. PubMed ID: 25618410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A straightforward guide to the sarcomeric basis of cardiomyopathies.
    Lopes LR; Elliott PM
    Heart; 2014 Dec; 100(24):1916-23. PubMed ID: 25271316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal and in silico models for the study of sarcomeric cardiomyopathies.
    Duncker DJ; Bakkers J; Brundel BJ; Robbins J; Tardiff JC; Carrier L
    Cardiovasc Res; 2015 Apr; 105(4):439-48. PubMed ID: 25600962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyocyte Dysfunction in Inherited Cardiomyopathies.
    Hassoun R; Budde H; Mügge A; Hamdani N
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Therapies for Prevention and Early Treatment of Cardiomyopathies.
    Repetti GG; Toepfer CN; Seidman JG; Seidman CE
    Circ Res; 2019 May; 124(11):1536-1550. PubMed ID: 31120825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Sarcomere Modulators Are Promising New Treatments for Cardiomyopathies.
    Tsukamoto O
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcomeric proteins and inherited cardiomyopathies.
    Morimoto S
    Cardiovasc Res; 2008 Mar; 77(4):659-66. PubMed ID: 18056765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac myosin binding protein-C: a novel sarcomeric target for gene therapy.
    Mamidi R; Li J; Gresham KS; Stelzer JE
    Pflugers Arch; 2014 Feb; 466(2):225-30. PubMed ID: 24310821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcomere neutralization in inherited cardiomyopathy: small-molecule proof-of-concept to correct hyper-Ca2+-sensitive myofilaments.
    Thompson BR; Martindale J; Metzger JM
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H36-43. PubMed ID: 27199134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell biology of sarcomeric protein engineering: disease modeling and therapeutic potential.
    Thompson BR; Metzger JM
    Anat Rec (Hoboken); 2014 Sep; 297(9):1663-9. PubMed ID: 25125179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving beyond simple answers to complex disorders in sarcomeric cardiomyopathies: the role of integrated systems.
    Deranek AE; Klass MM; Tardiff JC
    Pflugers Arch; 2019 May; 471(5):661-671. PubMed ID: 30848350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mutations in the SCN5A gene in cardiomyopathies.
    Zaklyazminskaya E; Dzemeshkevich S
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1799-805. PubMed ID: 26916278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes.
    Xu Q; Dewey S; Nguyen S; Gomes AV
    J Mol Cell Cardiol; 2010 May; 48(5):899-909. PubMed ID: 20298698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy.
    Ho CY
    Heart Fail Clin; 2010 Apr; 6(2):141-59. PubMed ID: 20347784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.
    van der Velden J; Tocchetti CG; Varricchi G; Bianco A; Sequeira V; Hilfiker-Kleiner D; Hamdani N; Leite-Moreira AF; Mayr M; Falcão-Pires I; Thum T; Dawson DK; Balligand JL; Heymans S
    Cardiovasc Res; 2018 Aug; 114(10):1273-1280. PubMed ID: 29912308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.